[
    [
        {
            "time": "",
            "original_text": "体检大数据心血管健康报告发布 近半数人群具有危险因素",
            "features": {
                "keywords": [
                    "体检",
                    "大数据",
                    "心血管",
                    "健康报告",
                    "危险因素"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "体检大数据心血管健康报告发布 近半数人群具有危险因素",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【国元医药|点评】昭衍新药2020半年报点评：Q2保持高增长态势，全年有望维持高景气",
            "features": {
                "keywords": [
                    "国元医药",
                    "昭衍新药",
                    "半年报",
                    "Q2",
                    "高增长",
                    "高景气"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国元医药|点评】昭衍新药2020半年报点评：Q2保持高增长态势，全年有望维持高景气",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "存量资金博弈 智品隆空仓求胜",
            "features": {
                "keywords": [
                    "存量资金",
                    "博弈",
                    "智品隆",
                    "空仓"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "存量资金博弈 智品隆空仓求胜",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]